Home » Topics » BioWorld Science

BioWorld Science
RSS

KNP-301 tested in mouse models of AMD

May 10, 2021

Telix cleared in Australia to begin phase III study of TLX-591 for metastatic CRPC

May 10, 2021

Enrollment begins in phase II study of NeoVax cancer vaccine in patients with CLL

May 10, 2021

NuBiyota starts phase II study of MET-2 in subjects with major depression

May 10, 2021

Enrollment ongoing in phase II study of JNJ-40411813 as adjunctive therapy in epilepsy

May 10, 2021

Allysta Pharmaceutical initiates first-in-human study of ALY-688-SR

May 10, 2021

Reduced galectin-3 observed in central serous chorioretinopathy

May 10, 2021

GQ-127 shows in vitro and in vivo antitumor activity in uveal melanoma

May 10, 2021

SparingVision studies ocular gene therapy SPVN-06 in primates

May 10, 2021

Study of a new CAIX-targeting radiotracer, [99mTc]PHC-102, for SPECT imaging in ccRCC patients

May 10, 2021

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...